Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
PhRMA submits comments to OSTP on enhancing clinical trial diversity
The White House ’s Office of Science and Technology Policy (OSTP) recently solicited stakeholder feedback on the clinical research infrastructure for emergency clinical trials, for which PhRMA submitted comments. PhRMA shares OSTP’s recognition of the importance of having a clinical trial infrastructure that su pports sites that are ready to respond to emergency situations like COVID-19. We also agree that one goal of such an infrastructure should be to support the expansion of clinical research into underserved communities by increasing diversity among both trial participants and clinical trial investigat ors.
Source: The Catalyst - March 21, 2023 Category: Pharmaceuticals Authors: Maria Apostolaros Tags: Research and Development Clinical Trials Coronavirus Source Type: news
Antibody Response Prolonged With COVID-19 Vaccine-Associated Symptoms
MONDAY, March 20, 2023 -- Messenger RNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination leads to transient antibody response, with more sustained response for mRNA-1273 than BNT162b2, for those experiencing...
Source: Drugs.com - Pharma News - March 20, 2023 Category: Pharmaceuticals Source Type: news
What we ’ve learned from three years of fighting COVID-19
Three years ago, amidst an unprecedented public health crisis, biopharmaceutical industrymade a commitment to fight COVID-19. Leveraging decades of research and investments in emerging technologies and scientific expertise, we dedicated ourselves to finding medical solutions to prevent, diagnose and treat those impacted by the coronavirus.
Source: The Catalyst - March 20, 2023 Category: Pharmaceuticals Tags: Research and Development PhRMA Member Company Vaccines Coronavirus Source Type: news
Progress Toward Effective Monoclonal Antibodies Treatments Against Covid-19 And Other Coronavirus Diseases
New advances in S2 antibodies may pave the way for more broadly effective monoclonal antibody treatments in the future.
Source: Forbes.com Healthcare News - March 17, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news
Genetic Data Links Covid Origins To Raccoon Dogs Sold At Wuhan Wet Market, Reports Say
This finding is the first piece of genetic evidence linking an animal being sold at the wet market to the coronavirus that caused the pandemic.
Source: Forbes.com Healthcare News - March 17, 2023 Category: Pharmaceuticals Authors: Siladitya Ray, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
InnovationRx: SVB Fallout; Plus, Helping Dogs Live Longer
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - March 15, 2023 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Editors' Pick editors-pick Newsletter No Paywall no-paywall Coronavirus technology alexknappblog Source Type: news
Covid-19 Origin: House Unanimously Approves Bill To Declassify Intelligence On Wuhan Lab
The Director of National Intelligence will have 90 days to release a report on de-classified information on the origin of Covid-19 to Congress, if signed by President Joe Biden.
Source: Forbes.com Healthcare News - March 10, 2023 Category: Pharmaceuticals Authors: Brian Bushard, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Gain-Of-Function Research And Covid-19: Could Too Much Oversight Slow Progress?
Infectious disease expert and biology professor Dave Wessner explores the scientific merit versus potential danger of experiments that change the genetic makeup of viruses and give them new abilities to better understand how they infect others and causes disease.
Source: Forbes.com Healthcare News - March 9, 2023 Category: Pharmaceuticals Authors: Dave Wessner, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Source Type: news
ACC: COVID-19 Vaccination Cuts Risk for Cardiac Events With SARS-CoV-2 Infection
TUESDAY, March 7, 2023 -- Partial or complete COVID-19 vaccination is associated with a lower risk for major adverse cardiac events (MACE) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a research letter...
Source: Drugs.com - Pharma News - March 7, 2023 Category: Pharmaceuticals Source Type: news
Breakthrough SARS-CoV-2 Similar for Chronic Liver Disease With, Without Cirrhosis
TUESDAY, March 7, 2023 -- Full vaccination cuts the risk for all-cause mortality for breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among chronic liver disease (CLD) patients with cirrhosis by two-thirds,...
Source: Drugs.com - Pharma News - March 7, 2023 Category: Pharmaceuticals Source Type: news
Biden Requests $1.6 Billion To Tackle Pandemic Aid Fraud
The White House, which claims the Trump administration could have detected fraudulent loans worth billions of dollars, says its anti-fraud push is separate from Republican investigations.
Source: Forbes.com Healthcare News - March 2, 2023 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
InnovationRx: ChatGPT Won ’t Fix Healthcare; Plus, Covid-19 Origin
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - March 2, 2023 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Coronavirus Editors' Pick editors-pick Newsletter No Paywall no-paywall technology alexknappblog Source Type: news
Impact of COVID-19 pandemic on the availability of maternal and child health products and childhood vaccines
ConclusionThis study illustrates that the availability of key essential medicines for maternal and child health in the study area was low. The overall stock-out situation of MCH products has worsened during COVID-19 compared to pre-COVID-19 pandemic. None of the surveyed MCH products met the ideal availability benchmark of 80% in the public hospitals. To allow governments to guarantee these products are constantly available and affordable, a variety of policy frameworks and choices addressing inevitable epidemics should exist.
Source: Journal of Pharmaceutical Policy and Practice - March 2, 2023 Category: Pharmaceuticals Source Type: research
Sticking To Healthy Lifestyle Prior Covid-19 Infection Might Lower Long Covid Risk
In a recent study published in JAMA Internal Medicine, a group of researchers found that women who had a healthy lifestyle before a Covid-19 infection had a substantially lower risk of long Covid.
Source: Forbes.com Healthcare News - February 27, 2023 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Source Type: news
U.S. Government Divided On Covid Lab Leak Theory —Here’s Where Each Agency Stands
The U.S. Energy Department concluded the coronavirus probably originated in a lab, news outlets reported over the weekend, reviving the years-long debate over the origins of the virus.
Source: Forbes.com Healthcare News - February 27, 2023 Category: Pharmaceuticals Authors: Ana Faguy, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
